Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey G Evers

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Frontiers in Psychiatry|August 15, 2022
Ketamine as a prophylactic resilience-enhancing agentAudrey G Evers, James W Murrough, Dennis S Charney, et al.
The American Journal of Psychiatry|May 19, 2026
Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled TrialJason M Tucciarone, Igor D Bandeira, Christine Blasey, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Frontiers in Psychiatry|August 15, 2022
Ketamine as a prophylactic resilience-enhancing agentAudrey G Evers, James W Murrough, Dennis S Charney, et al.
The American Journal of Psychiatry|May 19, 2026
Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled TrialJason M Tucciarone, Igor D Bandeira, Christine Blasey, et al.
Pageof 1